@BillGates: A lot of work remains, but it’s exciting to see positive data on a drug candidate that may alter the course of Alzheimer’s disease. https://t.co/h97EBGqWyJ

- October 30, 2019

http://twitter.com/BillGates

A lot of work remains, but it’s exciting to see positive data on a drug candidate that may alter the course of Alzheimer’s disease. https://t.co/h97EBGqWyJ
— Bill Gates (@BillGates) October 30, 2019

Search This Blog

True News

@BillGates: A lot of work remains, but it’s exciting to see positive data on a drug candidate that may alter the course of Alzheimer’s disease. https://t.co/h97EBGqWyJ

Comments

Post a Comment

Popular posts from this blog

@BillGates: I found the book to be valuable on a number of levels and will have more to say about it soon! https://t.co/Ur2aE81FyV

@BillGates: Foreign aid is one of the best investments that the U.S. can make. Now is the time to strengthen programs like @PEPFAR. https://t.co/vFHR9bY1Vx

@BillGates: There are few people I’ve learned more from over the years–especially about viruses–than Peter Piot. This Q&A with him is an excellent, easy-to-understand primer on #COVID19: https://t.co/dBntxKnybd https://t.co/R6M4fItYHU